These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9566226)

  • 21. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
    Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of synthetic tetrahydroindeno[2,1-c]quinolines on Leishmania mexicana.
    Hernández-Chinea C; Carbajo E; Sojo F; Arvelo F; Kouznetsov VV; Romero-Bohórquez AR; Romero PJ
    Parasitol Int; 2015 Dec; 64(6):479-83. PubMed ID: 26148815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplification of the H locus in Leishmania infantum.
    Chiquero MJ; Olmo A; Navarro P; Ruiz-Perez LM; Castanys S; Gonzalez-Pacanowska D; Gamarro F
    Biochim Biophys Acta; 1994 Nov; 1227(3):188-94. PubMed ID: 7986827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of itraconazole and terbinafine on Leishmania promastigotes.
    Zakai HA; Zimmo SKh; Fouad MA
    J Egypt Soc Parasitol; 2003 Apr; 33(1):97-107. PubMed ID: 12739804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High level arsenite resistance in Leishmania tarentolae is mediated by an active extrusion system.
    Dey S; Papadopoulou B; Haimeur A; Roy G; Grondin K; Dou D; Rosen BP; Ouellette M
    Mol Biochem Parasitol; 1994 Sep; 67(1):49-57. PubMed ID: 7838183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
    Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
    Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica.
    El Hajj R; Bou Youness H; Lachaud L; Bastien P; Masquefa C; Bonnet PA; El Hajj H; Khalifeh I
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006854. PubMed ID: 30462645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leishmanicidal activity of primary S-nitrosothiols against Leishmania major and Leishmania amazonensis: implications for the treatment of cutaneous leishmaniasis.
    de Souza GF; Yokoyama-Yasunaka JK; Seabra AB; Miguel DC; de Oliveira MG; Uliana SR
    Nitric Oxide; 2006 Nov; 15(3):209-16. PubMed ID: 16527502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Leishmania (Leishmania) amazonensis promastigotes resistant to pentamidine.
    Coelho AC; Gentil LG; da Silveira JF; Cotrim PC
    Exp Parasitol; 2008 Sep; 120(1):98-102. PubMed ID: 18511047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195.
    Guedes CES; Dias BRS; Petersen ALOA; Cruz KP; Almeida NJ; Andrade DR; Menezes JPB; Borges VM; Veras PST
    Mem Inst Oswaldo Cruz; 2018 Feb; 113(4):e170345. PubMed ID: 29412342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63.
    Connell ND; Medina-Acosta E; McMaster WR; Bloom BR; Russell DG
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11473-7. PubMed ID: 8265576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glibenclamide modulates glucantime activity and disposition in Leishmania major.
    Padrón-Nieves M; Díaz E; Machuca C; Romero A; Ponte Sucre A
    Exp Parasitol; 2009 Apr; 121(4):331-7. PubMed ID: 19135995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents.
    Taylor VM; Muñoz DL; Cedeño DL; Vélez ID; Jones MA; Robledo SM
    Exp Parasitol; 2010 Dec; 126(4):471-5. PubMed ID: 20685203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro.
    Freitas EO; Nico D; Guan R; Meyer-Fernandes JR; Clinch K; Evans GB; Tyler PC; Schramm VL; Palatnik-de-Sousa CB
    PLoS One; 2015; 10(4):e0124183. PubMed ID: 25909893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes.
    Miguel DC; Yokoyama-Yasunaka JK; Andreoli WK; Mortara RA; Uliana SR
    J Antimicrob Chemother; 2007 Sep; 60(3):526-34. PubMed ID: 17584801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of cutaneous leishmaniasis with allopurinol after failure of treatment with ketoconazole.
    Baum KF; Berens RL
    Clin Infect Dis; 1994 May; 18(5):813-5. PubMed ID: 8075279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tunicamycin-resistant Leishmania mexicana amazonensis: expression of virulence associated with an increased activity of N-acetylglucosaminyltransferase and amplification of its presumptive gene.
    Kink JA; Chang KP
    Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1253-7. PubMed ID: 2950522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the Synadenium carinatum latex lectin (ScLL) on Leishmania (Leishmania) amazonensis infection in murine macrophages.
    Afonso-Cardoso SR; Silva CV; Ferreira MS; Souza MA
    Exp Parasitol; 2011 May; 128(1):61-7. PubMed ID: 21320493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leishmania inactivation in human pheresis platelets by a psoralen (amotosalen HCl) and long-wavelength ultraviolet irradiation.
    Eastman RT; Barrett LK; Dupuis K; Buckner FS; Van Voorhis WC
    Transfusion; 2005 Sep; 45(9):1459-63. PubMed ID: 16131378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epoxy-α-lapachone has in vitro and in vivo anti-leishmania (Leishmania) amazonensis effects and inhibits serine proteinase activity in this parasite.
    Souza-Silva F; Bourguignon SC; Pereira BA; Côrtes LM; de Oliveira LF; Henriques-Pons A; Finkelstein LC; Ferreira VF; Carneiro PF; de Pinho RT; Caffarena ER; Alves CR
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1910-8. PubMed ID: 25583728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.